AVERY CATLIN - 12 May 2021 Form 4 Insider Report for Provention Bio, Inc. (PRVB)

Role
Director
Signature
/s/ Andrew Drechsler, as attorney-in-fact
Issuer symbol
PRVB
Transactions as of
12 May 2021
Net transactions value
$0
Form type
4
Filing time
14 May 2021, 19:48:49 UTC
Next filing
17 Jun 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRVB Stock Option (right to buy) Award $0 +23,000 $0.000000 23,000 12 May 2021 Common Stock, par value $0.0001 23,000 $6.80 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options will vest in full and become exercisable upon the earlier to occur of (a) the business day before the Issuer's next annual meeting of stockholders and (b) May 12, 2022.
F2 The securities were granted pursuant to the Issuer's Amended and Restated 2017 Equity Incentive Plan.